Biosynex: successful takeover bid for Theradiag


(CercleFinance.com) – Euronext Paris informed the AMF that on January 12, the latest date set for the filing of orders submitted to the takeover bid initiated by Biosynex for Theradiag shares, it received 2,826,997 shares in deposit.

In total, Biosynex holds 9,032,820 shares representing 68.86% of the capital and at least 68.56% of the voting rights. The minimum required condition of holding at the end of the offer being satisfied, it therefore has a positive result.

The settlement-delivery of the public tender offer will take place according to the schedule communicated by Euronext Paris. A later publication is yet to specify the dates and duration of the reopening of the offer.

Copyright © 2023 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.





Facebook


LinkedIn


E-mail





Source link -85